Civil Litigation,
Intellectual Property
Jul. 23, 2018
Tribal immunity does not apply in patent review, Federal Circuit rules
A Federal Circuit panel ruled Friday that tribal sovereign immunity does not apply in inter partes review of patents, quashing an attempt by Allergan PLC to extricate itself from challenges brought against its patents for a dry-eye medication.
Tribal sovereign immunity does not apply in inter partes review of patents, a panel of the U.S. Court of Appeals for the Federal Circuit ruled Friday, quashing an attempt by Allergan PLC to extricate itself from challenges brought against patents for a dry-eye medication.
In 2015, Allergan sued generic drug manufacturers for allegedly infringing on patents related to the chronic dry eye treatment Restasis. In response, Mylan Pharmac...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In